How is nasopharyngeal carcinoma lung metastasis diagnosed and what should be done

If you have nasopharyngeal cancer, you must take good care of yourself and actively seek treatment. Here is how to diagnose lung metastasis of nasopharyngeal cancer? What should you do?

Nasopharyngeal carcinoma is one of the most common tumors in my country, ranking first among head and neck tumors. It is most common in Guangdong, Guangxi, Fujian, Hunan and other provinces. In the early stage of clinical manifestation, blood may appear in the mucus; if the tumor grows and compresses the pharyngeal opening of the Eustachian tube, it may cause symptoms of otitis media such as tinnitus, stuffy ears and hearing loss; 60% of patients seek medical treatment because of swollen lymph nodes in the neck.

The symptoms of nasopharyngeal carcinoma lung metastasis are mostly located in the middle and outer zones of the lung fields on both sides, and the chances of metastasis in the left and right lungs are equal. Multiple metastases are often present, and the lesions are round with smooth edges. About 5% of cases are solitary nodules, which should be differentiated from primary lung cancer. Lung metastasis is often asymptomatic in the early stages. Most patients are found to have multiple and large lung metastases during routine chest X-ray examinations, or the tumor invades the pleura and causes pleural effusion. The patient will then experience coughing, chest pain, and shortness of breath. Some patients are misdiagnosed as having "stomach disease" because of pain in the left upper abdomen caused by left lung base metastases involving the pleura. Patients with such symptoms should undergo routine chest X-ray examinations to avoid delays in diagnosis and treatment.

If nasopharyngeal carcinoma metastasizes to the lungs, you can try biological therapy. Biological immunotherapy is harmless and has no toxic side effects on the body of patients with nasopharyngeal carcinoma metastases to the lungs. It is an autologous immune cell technology that uses certain biotechnologies to cultivate DC immune cells and CIK tumor-killing cells in a high-standard laboratory, and then uses a unique double-cultivation and double-infusion method to double-cultivate and double-infuse DC and CIK cells, and then combine them into one and infuse them back into the patient's body, directly killing cancer cells and rebuilding the autoimmune system.